drugset / Trial / NCT01069809
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of AGS-004, an immune therapy, for HIV-infected individuals. Safety and effectiveness will be tested while the individuals are both taking antiretroviral therapy (ART) medication and interrupting ART medication.
Timeline
- Start
- 2010-07
- Primary completion
- 2014-08
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGS-004 | Cell therapy | — | — |